Lineage Cell Therapeutics

LCTX

NYSE MKT LLCHealth Care

Income Statement

Total Revenue$9.5M

Gross Profit$9.17M

Operating Income$-21.48M

EBITDA$-18M

EBIT$-18.61M

Pre-tax Income$-68.93M

Net Income$-18.61M

Cash Equivalent$36.68M

Total Debt$2.87M

Book Value$69.92M

Book Value Per Share0.37

Return on Equity (ROE)-23.74%

Return on Assets (ROA)-16.44%

Return on Invested Capital (ROI)-23.70%

Net Profit Margin-195.90%

Current Ratio3.65

Quick Ratio3.47

Long-Term Debt / Equity0.00